Loading...
XKRX
003090
Market cap584mUSD
May 15, Last price  
20,350.00KRW
1D
1.46%
1Q
-2.90%
Jan 2017
128.15%
Name

Daewoong Co Ltd

Chart & Performance

D1W1MN
XKRX:003090 chart
P/E
14.38
P/S
0.43
EPS
1,415.61
Div Yield, %
—
Shrs. gr., 5y
-1.09%
Rev. gr., 5y
7.24%
Revenues
1.94t
+6.71%
500,880,459,000607,247,194,000695,010,620,000766,644,083,000670,825,226,000270,641,226,890306,154,896,540843,534,264,430893,976,778,700996,645,900,6501,015,010,730,4701,124,075,727,1401,231,173,935,6601,365,679,369,3301,355,337,386,7501,511,373,580,8101,697,338,482,5801,815,103,675,1241,936,916,852,590
Net income
57.89b
-62.08%
24,284,888,00029,629,972,00015,878,328,00020,011,814,00032,363,158,00043,268,255,00044,199,500,18040,771,653,96023,811,158,08038,623,412,96019,831,075,11066,250,630,10029,863,274,89062,439,349,48098,378,893,02078,730,194,980102,565,588,550152,665,121,74057,885,500,080
CFO
162.38b
-21.04%
52,235,463,00041,661,606,00056,712,968,000118,036,604,00034,417,099,00010,404,679,58027,615,344,38086,193,904,77046,607,316,99074,916,093,23018,755,841,540147,774,279,09045,380,803,380138,512,224,900145,365,812,640133,175,353,200149,081,680,740205,654,597,630162,384,530,560
Dividend
Dec 27, 2023100 KRW/sh
Earnings
Aug 12, 2025

Profile

Daewoong Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals. It also engages in the leasing of real estates. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1961 and is headquartered in Seongnam-si, South Korea.
URL
http://www.daewoongholdings.com/
IPO date
Jun 26, 1973
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,936,916,853
6.71%
1,815,103,675
6.94%
1,697,338,483
12.30%
Cost of revenue
1,464,777,505
1,436,163,903
1,308,778,381
Unusual Expense (Income)
NOPBT
472,139,348
378,939,772
388,560,102
NOPBT Margin
24.38%
20.88%
22.89%
Operating Taxes
46,914,357
11,083,066
34,664,176
Tax Rate
9.94%
2.92%
8.92%
NOPAT
425,224,991
367,856,706
353,895,926
Net income
57,885,500
-62.08%
152,665,122
48.85%
102,565,589
30.27%
Dividends
(8,194,805)
(8,119,145)
(4,156,569)
Dividend yield
0.93%
0.95%
0.49%
Proceeds from repurchase of equity
(9,908,541)
174,631
BB yield
1.16%
-0.02%
Debt
Debt current
355,925,461
381,763,137
234,819,026
Long-term debt
330,804,262
70,994,216
212,875,965
Deferred revenue
100,819,801
36,403,016
Other long-term liabilities
59,612,103
164,390,921
95,069,791
Net debt
280,881,871
(170,098,077)
87,620,111
Cash flow
Cash from operating activities
162,384,531
205,654,598
149,081,681
CAPEX
(262,588,681)
(181,443,241)
(117,622,887)
Cash from investing activities
(365,546,159)
(204,815,148)
(105,493,345)
Cash from financing activities
227,823,156
(28,983,853)
22,571,774
FCF
139,081,922
228,550,559
257,684,782
Balance
Cash
264,138,795
267,163,536
386,740,192
Long term investments
141,709,057
355,691,893
(26,665,312)
Excess cash
309,002,010
532,100,245
275,207,955
Stockholders' equity
1,481,240,692
1,143,077,752
1,407,678,113
Invested Capital
1,530,583,506
1,517,935,650
1,551,298,157
ROIC
27.90%
23.97%
23.64%
ROCE
20.00%
18.48%
21.02%
EV
Common stock shares outstanding
40,875
41,354
41,577
Price
21,600.00
4.60%
20,650.00
1.47%
20,350.00
-34.46%
Market cap
882,894,298
3.39%
853,956,755
0.93%
846,093,354
-34.42%
EV
1,669,764,982
1,185,861,327
1,384,380,566
EBITDA
530,924,645
433,160,957
436,839,581
EV/EBITDA
3.15
2.74
3.17
Interest
7,566,450
13,993,951
8,351,007
Interest/NOPBT
1.60%
3.69%
2.15%